Rao Mantri serves as CMfgO and oversees the technology and manufacturing strategy. Under his leadership, Astellas continues to accelerate product development through launch and ensure a reliable supply, leveraging our innovative capabilities across modalities.

Rao brings more than 24 years of leadership and experience across the pharmaceutical value chain, including global product development, manufacturing and supply chain management during his tenure at Bristol Myers Squibb. Over his career, he has contributed to the development and commercialization of many innovative pharmaceutical and biologic products. He joined Astellas in February 2025 and was appointed CMfgO in April 2025.

Rao’s strong expertise across modalities and technologies is complemented by his strategic insights, focused execution and ability to build across cultures and functions. He is committed to creating and delivering innovative medicines to patients around the world, with a sense of urgency.